跳至主要内容
临床试验/NCT07043712
NCT07043712进行中(未招募)不适用

Human Pulse Consumption, the Microbiome, and Meal Satiety

University of Missouri-Columbia1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2023年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
44
试验地点
1
主要终点
gut microbial change

研究概览

简要总结

The purpose of the study is to investigate the effects of pulse consumption versus no pulse consumption on the gut microbiome, meal satiety, and short-chain fatty acid metabolomics.

详细描述

  1. Investigate the acute and chronic effects of pulse consumption on the microbiome and plasma SCFA metabolomics in overweight subjects fed a high pulse (n=22) diet versus a no pulse containing diet (n=22).
  2. Furthermore, we will quantitate the rate of production of plasma SCFA, markers of satiety (PYY, GLP-1 and ghrelin), blood lipids, and carbohydrate (CHO) metabolism (glucose levels and oxidation) during a standardized meal to determine the effects of consuming pulses on appetite and satiety after acute and chronic dietary consumption.
  3. We will conduct subjective appetite assessments to investigate appetite control over the short- and long-term.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Men and women (premenopausal only)
  • •Age 20-55y (we will attempt to start baseline testing at the same time of the menstrual cycle (luteal) for the women
  • •BMI ≥25 or ≤40 kg/m2 (most at risk for metabolic abnormalities and will benefit from a pulse intervention-2/3 of Americans are overweight or obese)
  • •Weight stable (no fluctuations in body weight of greater than 4 kg in the last 3 months)
  • •Willing to consume a research diet
  • •Willing to provide blood and fecal samples
  • •Sedentary to low active physical activity status (less than 7200 steps per day)
  • •Stably treated with statin drugs, anti-hypertensives, and anti-depressants. These are acceptable as long as the drug category does not alter appetite, body weight, or the microbiome (if known)
  • •Pre-diabetes acceptable (glucose <125 mg/dL or HbA1c < 6.5%)
  • •At least one characteristic of the metabolic syndrome (but not diabetic)
  • •A large waistline: 35 inches or more for women 40 inches or more for men
  • •High triglycerides: 150 mg/dL or higher
  • •Low HDLc level: <50 mg/dL for women <40 mg/dL for men
  • •High blood pressure ≥130/85 mmHg
  • •Fasting blood sugar ≥100 mg/dL - Pre-diabetes acceptable (glucose <125 mg/dL or HbA1c <6.5%) -

排除标准

  • •Pregnant or lactating
  • •Postmenopausal (evidence suggests an interplay between the gut microbiome)
  • •BMI of <25 or >40 kg/m2
  • •Use of medications that affect the gut microbiome (e.g. antibiotics)
  • •Taking medications known to affect appetite (e.g., phentermine) or gastrointestinal function (e.g., metformin)
  • •On a special diet or undergoing weight loss, vegetarian, or other restricted dietary patterns
  • •Ad libitum intake of fiber above 25g/day (mean intake in the US population is 17g/day) and < 10g/d
  • •History of disease (example colon cancer, HIV, cardiovascular disease, psychiatric disorders, etc.)
  • •Use of tobacco products

研究组 & 干预措施

High pulse consumption

Experimental

Subjects are provided a high pulse diet for 4-weeks. Tests include: blood biochemistries, a meal tolerance test, body composition measured via DEXA, surveys, fecal sample

干预措施: High pulse consumption (Dietary Supplement)

No pulse consumption

No Intervention

Subjects are provided a diet that has no pulses for 4-weeks. Tests include: blood biochemistries, a meal tolerance test, body composition measured via DEXA, surveys, fecal sample

结局指标

主要结局

gut microbial change

时间窗: baseline to 4 weeks

assessed via 16s rRNA gene sequencing from fecal samples collection

Change in appetite hormones

时间窗: baseline to 4 weeks

GLP-1 measurement in plasma samples

次要结局

  • cardiometabolic risk factors(baseline to 4 weeks)
  • Change in subjective appetite(baseline to 4 weeks)
  • short chain fatty acid metabolomics(baseline to 4 weeks)
  • Body composition(baseline to 4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katherene Anguah

Associate Professor, Nutrition and Exercise Physiology

University of Missouri-Columbia

研究点 (1)

Loading locations...

相似试验